Ingredients in Alergeze have been shown to or may:
- Assists in the symptomatic relief and management of seasonal and perennial allergic rhinitis.
- A unique combination of NRA2™ plus Bromelains and Quercetin.
- Used as part of the Metagenics Allergy and Reactivity Reduction Program.
For symptomatic relief of allergies and hay fever: A multicentre clinical trial involving 545 patients concluded that NRA2™ significantly reduced major symptoms of seasonal and perennial allergic rhinitis including sneezing, rhinorrhoea and nasal congestion. Furthermore, absolute eosinophil count, mucociliary clearance time, peak expiratory flow rate and peak nasal flow rate also improved. In another trial, patients also reported a 70% improvement on quality of life parameters after 3 months. NRA2™ can be used alongside allergy medication without any additional adverse side effects.
Modulates histamine release and inflammation associated with allergic reactions: Alergeze contains a potent combination of ingredients that exhibit antihistamine, antioxidant and anti-inflammatory activity. NRA2™ and Quercetin assist with mast cell stabilisation to inhibit histamine release and down regulate the production of allergic cytokines, inflammatory leukotrienes and prostaglandins.8 Bromelains induces proteolytic activity during inflammation and is an effective mucolytic agent.
Immune modulation: Quercetin may assist with immune tolerance by improving T helper 1 (Th1) and T helper 2 (Th2) balance. Allergic sensitisation involves Th2 like adaptive immunity and production of antibodies.
Adults: Take 2 tablets, twice daily with food.
|
Each tablet contains: | |
|
Quercetin dihydrate |
500 mg |
|
Bromelains |
9 million PU (282 mg) |
|
NRA2TM Proprietary Polyherbal Complex containing dry herbal extracts equivalent to: | |
|
Terminalia chebula (Terminalia myrobalan), fruit pericap |
129 mg |
|
Derived from dry fruit pericap | 644 mg |
| Phyllanthus emblica (Emblic), fruit pericarp | 78 mg |
| Derived from dry fruit pericap | 391 mg |
| Terminalia bellirica (Myrobalan), fruit pericap | 76 mg |
| Derived from dry fruit pericap | 380 mg |
| Albizia lebbeck (Albizia), stem bark | 24 mg |
| Derived from dry stem bark | 189 mg |
| Piper longum (Long pepper), fruit | 11 mg |
| Derived from dry fruit | 15 mg |
| Zingiber officinale (Ginger), rhizome | 5.5 mg |
| Derived from dry rhizome | 15 mg |
| Piper nigrum (Black pepper), fruit | 7.1 mg |
| Derived from dry fruit | 15 mg |
Free from animal products, dairy protein, lactose, eggs, gluten, wheat, nuts, yeast and soy protein. Free from artificial colours and flavours.
Excipients: Calcium hydrogen phosphate dihydrate, Carnauba Wax Colloidal anhydrous silica, Croscarmellose sodium, Crospovidone, Hypromellose, Macrogol 400, Magnesium stearate, Maltodextrin, Microcrystalline cellulose, Potassium hydroxide and Sodium hydroxide.
Not all cautions and contraindications are listed. For full details, references or more information contact Metagenics in Australia on 1800 777 648 or in New Zealand on 0508 227 744.
Ingredients in Alergeze have been shown to or may:
- Assists in the symptomatic relief and management of seasonal and perennial allergic rhinitis.
- A unique combination of NRA2™ plus Bromelains and Quercetin.
- Used as part of the Metagenics Allergy and Reactivity Reduction Program.
For symptomatic relief of allergies and hay fever: A multicentre clinical trial involving 545 patients concluded that NRA2™ significantly reduced major symptoms of seasonal and perennial allergic rhinitis including sneezing, rhinorrhoea and nasal congestion. Furthermore, absolute eosinophil count, mucociliary clearance time, peak expiratory flow rate and peak nasal flow rate also improved. In another trial, patients also reported a 70% improvement on quality of life parameters after 3 months. NRA2™ can be used alongside allergy medication without any additional adverse side effects.
Modulates histamine release and inflammation associated with allergic reactions: Alergeze contains a potent combination of ingredients that exhibit antihistamine, antioxidant and anti-inflammatory activity. NRA2™ and Quercetin assist with mast cell stabilisation to inhibit histamine release and down regulate the production of allergic cytokines, inflammatory leukotrienes and prostaglandins.8 Bromelains induces proteolytic activity during inflammation and is an effective mucolytic agent.
Immune modulation: Quercetin may assist with immune tolerance by improving T helper 1 (Th1) and T helper 2 (Th2) balance. Allergic sensitisation involves Th2 like adaptive immunity and production of antibodies.
Adults: Take 2 tablets, twice daily with food.
|
Each tablet contains: | |
|
Quercetin dihydrate |
500 mg |
|
Bromelains |
9 million PU (282 mg) |
|
NRA2TM Proprietary Polyherbal Complex containing dry herbal extracts equivalent to: | |
|
Terminalia chebula (Terminalia myrobalan), fruit pericap |
129 mg |
|
Derived from dry fruit pericap | 644 mg |
| Phyllanthus emblica (Emblic), fruit pericarp | 78 mg |
| Derived from dry fruit pericap | 391 mg |
| Terminalia bellirica (Myrobalan), fruit pericap | 76 mg |
| Derived from dry fruit pericap | 380 mg |
| Albizia lebbeck (Albizia), stem bark | 24 mg |
| Derived from dry stem bark | 189 mg |
| Piper longum (Long pepper), fruit | 11 mg |
| Derived from dry fruit | 15 mg |
| Zingiber officinale (Ginger), rhizome | 5.5 mg |
| Derived from dry rhizome | 15 mg |
| Piper nigrum (Black pepper), fruit | 7.1 mg |
| Derived from dry fruit | 15 mg |
Free from animal products, dairy protein, lactose, eggs, gluten, wheat, nuts, yeast and soy protein. Free from artificial colours and flavours.
Excipients: Calcium hydrogen phosphate dihydrate, Carnauba Wax Colloidal anhydrous silica, Croscarmellose sodium, Crospovidone, Hypromellose, Macrogol 400, Magnesium stearate, Maltodextrin, Microcrystalline cellulose, Potassium hydroxide and Sodium hydroxide.
Not all cautions and contraindications are listed. For full details, references or more information contact Metagenics in Australia on 1800 777 648 or in New Zealand on 0508 227 744.